Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
02/2006
02/02/2006CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/01/2006EP1620389A1 Halogen substituted 3,3-diphenylpropylamines (tolterodine) having antimuscarinic activity
02/01/2006EP1334082A4 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
02/01/2006EP1257525B1 Stabilizing agent for hydroxylamine solutions
02/01/2006EP0905167B1 Diaminobenzene derivatives, polyimides prepared therefrom, and alignment film for liquid crystals
02/01/2006CN1239470C Process for producing 1,3-bis(3-aminophenoxy) benzene
02/01/2006CN1239469C Chiral amine compound and its synthesis and use
02/01/2006CN1239468C Method for the racemization of optically active amines
02/01/2006CN1239467C Primary intermediates for oxidative coloration of hair
01/2006
01/26/2006WO2005108409A3 Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts
01/26/2006US20060020041 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections
01/25/2006EP1619180A1 CaSR ANTAGONIST
01/25/2006EP1097158B1 Ligands for metals and metal-catalyzed processes
01/25/2006CN1726603A Charge transport compositions and electronic devices made with such compositions
01/25/2006CN1726183A Cardiolipin molecules and method of synthesis
01/24/2006US6988431 Removal tool for locking nut, bolt and clip systems and assemblies
01/19/2006US20060014832 Highly pure bases of 3,3-dipheyl propylamine monoesters
01/19/2006US20060014779 3-Aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norephinephrine reuptake
01/18/2006CN1721052A Waterpower liquid
01/18/2006CN1236845C Bis (perfluoroalkanesulfonyl)imides and their salts as surfactants/additives for applications having extreme environments and methods thereof
01/17/2006US6987132 Enediyne compounds and methods related thereto
01/17/2006CA2334713C Therapeutic biaryl derivatives
01/17/2006CA2177171C Novel substituted oxazolidines
01/12/2006WO2006004979A2 An isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards
01/12/2006WO2006004977A2 Process for the optical resolution and recycling of tomoxetine
01/12/2006WO2006004923A2 Enantiomerically pure atomoxetine and tomoxetine mandelate
01/12/2006WO2006003194A1 Process for preparing amines and a carboxamide thereof
01/12/2006WO2005113483A3 Levalbuterol hydrochloride polymorph a
01/12/2006US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
01/12/2006CA2561866A1 Process for the optical resolution and recycling of tomoxetine
01/12/2006CA2561387A1 An isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards
01/12/2006CA2561386A1 Enantiomerically pure atomoxetine and tomoxetine mandelate
01/12/2006CA2560899A1 Process for the preparation of atomoxetine hydrochloride
01/11/2006EP1614672A1 An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
01/11/2006EP1613584A1 Highly pure bases of 3,3-diphenyl propylamine monoesters
01/11/2006CN1720280A Novel diaminobenzene derivative, polyimide precursor and polyimide obtained therefrom, and aligning agent for liquid crystal
01/11/2006CN1235870C Novel use of phenyl hetero alkylamine derivatives
01/05/2006US20060004106 For urogenital disorders; improved side effect reduction, bioavailability, pharmacokinetics and half-life; N,N-diisopropyl-3-(2-methoxy-5-trifluoromethylphenyl)-3-phenylpropanamine
01/05/2006US20060002853 Stilbene derivatives and their use for binding and imaging amyloid plaques
01/04/2006EP1611091A1 Novel compounds
01/03/2006US6982350 reduction of 4,5-dimethoxy-1-cyano-benzocyclobutane, resolution with optically active diacid (N-acetyl-L-glutamic acid), amidification and reduction; improved yield and optical purity; chemical intermediates; antiischemic agents
01/03/2006US6982335 Synthesis of substituted thiazoline carboxylic acids
12/2005
12/29/2005WO2005123659A1 Method of synthesising (1s)-4,5-dimethoxy-1- (methylaminomethyl)-benzocyclobutane and the addition salts thereof, and use of same for the synthesis of ivabradine and the pharmaceutically-acceptable addition salts thereof
12/29/2005WO2005123018A1 Agent for dyeing keratin fibers
12/29/2005US20050288530 Amine derivative
12/29/2005US20050287108 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1185563B1 Method of polymerization
12/28/2005EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
12/22/2005WO2005121067A1 Composition, particularly a cosmetic composition, comprising ((dialkylamino)alkoxy) ethanol ester
12/22/2005WO2005120152A2 Cationic lipids and methods of use
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005CA2569645A1 Cationic lipids and methods of use
12/21/2005EP1607385A1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
12/21/2005CN1709859A Method for preparing dextroa-[2-(naphthoxy, ethyl] phenyl methylamine derivatives
12/21/2005CN1232501C Preparing technology for cyclohexanol derivatives used to prepare the intermediate of Venlafaxine
12/20/2005CA2302412C Aminoalkylphenol derivatives and related compounds
12/15/2005WO2005118525A1 Synthesis of amino-alkoxy-heptanoic alkyl ester
12/15/2005WO2005118523A1 Amino-propanol derivatives
12/15/2005US20050277645 Sleep inducing compounds and methods relating thereto
12/15/2005CA2567914A1 Synthesis of amino-alkoxy-heptanoic alkyl ester
12/15/2005CA2562332A1 Amino-propanol derivatives
12/14/2005CN1708475A Aromatic amine derivative and organic electroluminescent element employing the same
12/14/2005CN1706813A Medicine precursor containing long chain fatty acyl group substituted venlafaxine and its prepn and use
12/14/2005CN1231458C Novel aryloxy-alkyl-dialkylamines compound
12/14/2005CN1231457C Substituted cycloheptaene and its preparation process and use
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/08/2005WO2005115994A1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof
12/08/2005WO2005115970A1 p-TERPHENYL COMPOUND AND PHOTOSENSITIVE BODY FOR ELECTROPHOTOGRAPHY USING SUCH COMPOUND
12/08/2005WO2005091754A3 Novel cyclopentenedione antifungal compounds and methods for their use
12/08/2005US20050272822 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
12/08/2005US20050272821 Levalbuterol hydrochloride Polymorph A
12/08/2005US20050272665 Synthesis of alpha-amino-beta-alkoxy-carboxylic acid esters
12/08/2005DE102004023529A1 Verfahren zur kontinuierlichen Herstellung eines Amins Process for the continuous preparation of an amine
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601640A2 Process for preparation of phenethylamine derivatives
12/07/2005EP1432675B1 Method for producing vanillylamine hydrochloride
12/06/2005CA2235840C Phenylethanolamine compounds useful as .beta.3 agonist, process for producing the same, and intermediates in the production of the same
12/06/2005CA2220389C Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2h-3,1-benzoxazin-2-one
12/05/2005WO2005116054A1 Process for preparing acyclic hcv protease inhibitors
12/05/2005CA2568008A1 Process for preparing acyclic hcv protease inhibitors
12/01/2005WO2005113506A1 Compounds and compositions as ppar modulators
12/01/2005WO2005113487A2 Polyurea compositions and compounds for the preparation thereof
12/01/2005WO2005113483A2 Levalbuterol hydrochloride polymorph a
12/01/2005WO2005113482A1 Levalbuterol hydrochloride polymorph b
12/01/2005WO2005113481A1 Preparation of levalbuterol hydrochloride
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
12/01/2005WO2005070873A3 Alkoxylated amines
12/01/2005US20050267219 Enantiomers of N-desmethyl venlafaxine
12/01/2005US20050267218 4-Hydroxymethyl-1-Aryl-cyclohexylamine compounds
12/01/2005US20050267216 suspending or forming a slurry of the R enantiomer of albuterol dibenzoyl tartrate complex in at least one solvent;adding hydrogen chloride in a C1-C4 alcohol to the suspension or slurry until levalbuterol hydrochloride Polymorph B is obtained
12/01/2005US20050267206 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
12/01/2005US20050267151 Hepatitis C; preparing 8-bromo-7-alkoxyquinolines 2-substituted with a hetercyclic ring having an amine, carbamate, amine or urea group an 4-substituted with a 3-prolineoxy- group or derivative; intermediates
12/01/2005CA2566605A1 Polyurea compositions and compounds for the preparation thereof
12/01/2005CA2564365A1 Compounds and compositions as ppar modulators
12/01/2005CA2556921A1 Levalbuterol hydrochloride polymorph b
12/01/2005CA2556920A1 Levalbuterol hydrochloride polymorph a
12/01/2005CA2556904A1 Preparation of levalbuterol hydrochloride
11/2005
11/30/2005CN1703393A Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 140